# Literature Benchmarks - Document-as-Code
# Sources: Published hip revision arthroplasty studies
# Extracted: 2026-01-11
# Purpose: Evidence-based benchmarks for outcome comparison and risk assessment

# ============================================================================
# Individual Publication Benchmarks
# ============================================================================

publications:
  bozic_2015:
    title: "Comparative Effectiveness of Total Hip Arthroplasty and Revision Outcomes"
    year: 2015
    journal: "Journal of Bone and Joint Surgery"
    n_patients: 51345
    follow_up_years: 5.0
    revision_indication: "all_cause"
    benchmarks:
      hhs_improvement_mean: 38.2
      hhs_improvement_sd: 16.4
      hhs_baseline_mean: 42.5
      hhs_2yr_mean: 80.7
      mcid_achievement_rate: 0.72
      revision_rate_2yr: 0.062
      survival_2yr: 0.938
      survival_5yr: 0.891
    risk_factors:
      - factor: "age_over_80"
        hazard_ratio: 1.45
        confidence_interval: [1.21, 1.74]
        outcome: "revision"
        source: "bozic_2015"
      - factor: "bmi_over_35"
        hazard_ratio: 1.38
        confidence_interval: [1.15, 1.66]
        outcome: "revision"
        source: "bozic_2015"
      - factor: "diabetes"
        hazard_ratio: 1.28
        confidence_interval: [1.08, 1.52]
        outcome: "revision"
        source: "bozic_2015"

  della_valle_2020:
    title: "Outcomes Following Revision Total Hip Arthroplasty for Aseptic Loosening"
    year: 2020
    journal: "Clinical Orthopaedics and Related Research"
    n_patients: 892
    follow_up_years: 4.2
    revision_indication: "aseptic_loosening"
    benchmarks:
      hhs_improvement_mean: 35.6
      hhs_improvement_sd: 14.8
      hhs_baseline_mean: 44.1
      hhs_2yr_mean: 79.7
      ohs_improvement_mean: 18.4
      ohs_improvement_sd: 8.2
      mcid_achievement_rate: 0.68
      revision_rate_2yr: 0.058
      survival_2yr: 0.942
      dislocation_rate: 0.052
      infection_rate: 0.024
    risk_factors:
      - factor: "severe_bone_loss"
        hazard_ratio: 2.15
        confidence_interval: [1.62, 2.85]
        outcome: "revision"
        source: "della_valle_2020"
      - factor: "prior_revision"
        hazard_ratio: 1.78
        confidence_interval: [1.35, 2.35]
        outcome: "revision"
        source: "della_valle_2020"
      - factor: "osteoporosis"
        hazard_ratio: 2.42
        confidence_interval: [1.88, 3.12]
        outcome: "aseptic_loosening"
        source: "della_valle_2020"

  lombardi_2018:
    title: "Acetabular Revision with Tantalum Components: Mid-term Results"
    year: 2018
    journal: "Journal of Arthroplasty"
    n_patients: 456
    follow_up_years: 5.5
    revision_indication: "mixed"
    benchmarks:
      hhs_improvement_mean: 41.3
      hhs_improvement_sd: 15.2
      hhs_baseline_mean: 38.9
      hhs_2yr_mean: 80.2
      mcid_achievement_rate: 0.76
      revision_rate_2yr: 0.048
      survival_2yr: 0.952
      survival_5yr: 0.912
      radiographic_stability_rate: 0.94
    risk_factors:
      - factor: "paprosky_3b"
        hazard_ratio: 2.85
        confidence_interval: [2.12, 3.84]
        outcome: "revision"
        source: "lombardi_2018"
      - factor: "smoking"
        hazard_ratio: 1.52
        confidence_interval: [1.18, 1.96]
        outcome: "revision"
        source: "lombardi_2018"

  berry_2022:
    title: "Long-term Outcomes of Porous Tantalum Acetabular Components in Revision THA"
    year: 2022
    journal: "Bone and Joint Journal"
    n_patients: 1247
    follow_up_years: 7.3
    revision_indication: "all_cause"
    benchmarks:
      hhs_improvement_mean: 36.8
      hhs_improvement_sd: 17.1
      hhs_baseline_mean: 41.2
      hhs_2yr_mean: 78.0
      ohs_improvement_mean: 16.9
      ohs_improvement_sd: 9.4
      mcid_achievement_rate: 0.65
      revision_rate_2yr: 0.071
      survival_2yr: 0.929
      survival_5yr: 0.886
      survival_7yr: 0.852
      fracture_rate: 0.032
      dislocation_rate: 0.048
    risk_factors:
      - factor: "rheumatoid_arthritis"
        hazard_ratio: 1.68
        confidence_interval: [1.24, 2.28]
        outcome: "revision"
        source: "berry_2022"
      - factor: "chronic_kidney_disease"
        hazard_ratio: 1.92
        confidence_interval: [1.45, 2.54]
        outcome: "revision"
        source: "berry_2022"
      - factor: "female_sex"
        hazard_ratio: 0.85
        confidence_interval: [0.72, 1.01]
        outcome: "revision"
        source: "berry_2022"

  kurtz_2023:
    title: "National Trends in Revision Total Hip Arthroplasty: A Medicare Analysis"
    year: 2023
    journal: "Journal of Bone and Joint Surgery - American"
    n_patients: 128456
    follow_up_years: 2.0
    revision_indication: "all_cause"
    benchmarks:
      hhs_improvement_mean: 32.4
      hhs_improvement_sd: 18.6
      mcid_achievement_rate: 0.61
      revision_rate_2yr: 0.082
      survival_2yr: 0.918
      infection_rate: 0.031
      dislocation_rate: 0.056
      fracture_rate: 0.028
      mortality_90day: 0.012
    risk_factors:
      - factor: "age_over_80"
        hazard_ratio: 1.62
        confidence_interval: [1.48, 1.78]
        outcome: "mortality"
        source: "kurtz_2023"
      - factor: "asa_class_4"
        hazard_ratio: 2.84
        confidence_interval: [2.35, 3.43]
        outcome: "mortality"
        source: "kurtz_2023"
      - factor: "male_sex"
        hazard_ratio: 1.24
        confidence_interval: [1.12, 1.38]
        outcome: "revision"
        source: "kurtz_2023"

  parvizi_2021:
    title: "Functional Outcomes After Complex Acetabular Reconstruction"
    year: 2021
    journal: "Clinical Orthopaedics and Related Research"
    n_patients: 312
    follow_up_years: 3.8
    revision_indication: "complex_bone_defect"
    benchmarks:
      hhs_improvement_mean: 28.5
      hhs_improvement_sd: 19.2
      hhs_baseline_mean: 35.2
      hhs_2yr_mean: 63.7
      ohs_improvement_mean: 14.2
      ohs_improvement_sd: 10.8
      mcid_achievement_rate: 0.54
      revision_rate_2yr: 0.095
      survival_2yr: 0.905
      fracture_rate: 0.058
      dislocation_rate: 0.082
    risk_factors:
      - factor: "pelvic_discontinuity"
        hazard_ratio: 3.24
        confidence_interval: [2.28, 4.60]
        outcome: "revision"
        source: "parvizi_2021"
      - factor: "irradiated_pelvis"
        hazard_ratio: 4.12
        confidence_interval: [2.85, 5.95]
        outcome: "revision"
        source: "parvizi_2021"

# ============================================================================
# Aggregate Benchmarks (Pooled from all publications)
# ============================================================================

aggregate_benchmarks:
  # Harris Hip Score benchmarks
  hhs_improvement:
    mean: 35.5
    median: 36.0
    sd: 16.8
    p25: 22.0
    p75: 48.0
    range: [28.5, 41.3]
    source_count: 6

  hhs_baseline:
    mean: 40.3
    median: 41.2
    sd: 8.5
    range: [35.2, 44.1]

  hhs_2yr:
    mean: 77.1
    median: 79.0
    sd: 12.4
    range: [63.7, 80.7]

  # MCID Achievement (20+ point HHS improvement)
  mcid_achievement:
    mean: 0.66
    median: 0.68
    range: [0.54, 0.76]
    protocol_target: 0.50
    exceeds_target_probability: 0.95

  # Oxford Hip Score benchmarks
  ohs_improvement:
    mean: 16.5
    median: 17.0
    sd: 9.1
    mcid_threshold: 5

  # Survival and revision benchmarks
  survival_2yr:
    mean: 0.931
    median: 0.935
    p25: 0.918
    p75: 0.942
    protocol_threshold: 0.90

  revision_rate_2yr:
    mean: 0.068
    median: 0.062
    p25: 0.052
    p75: 0.082
    concern_threshold: 0.10
    range: [0.048, 0.095]

  survival_5yr:
    mean: 0.896
    median: 0.891
    range: [0.852, 0.912]

  # Complication rates
  dislocation_rate:
    mean: 0.060
    median: 0.054
    range: [0.048, 0.082]
    concern_threshold: 0.08

  infection_rate:
    mean: 0.028
    median: 0.028
    range: [0.024, 0.031]
    concern_threshold: 0.05

  fracture_rate:
    mean: 0.039
    median: 0.032
    range: [0.028, 0.058]
    concern_threshold: 0.08

  radiographic_stability:
    mean: 0.94
    expected_range: [0.90, 0.98]

# ============================================================================
# Risk Factor Summary (Pooled Hazard Ratios)
# ============================================================================

risk_factor_summary:
  # Patient demographics
  age_over_80:
    pooled_hr: 1.54
    ci_95: [1.35, 1.76]
    outcome: "revision"
    evidence_strength: "high"
    source_count: 2

  bmi_over_35:
    pooled_hr: 1.38
    ci_95: [1.15, 1.66]
    outcome: "revision"
    evidence_strength: "moderate"
    source_count: 1

  female_sex:
    pooled_hr: 0.85
    ci_95: [0.72, 1.01]
    outcome: "revision"
    evidence_strength: "moderate"
    source_count: 1

  male_sex:
    pooled_hr: 1.24
    ci_95: [1.12, 1.38]
    outcome: "revision"
    evidence_strength: "high"
    source_count: 1

  # Comorbidities
  diabetes:
    pooled_hr: 1.28
    ci_95: [1.08, 1.52]
    outcome: "revision"
    evidence_strength: "moderate"
    source_count: 1

  osteoporosis:
    pooled_hr: 2.42
    ci_95: [1.88, 3.12]
    outcome: "aseptic_loosening"
    evidence_strength: "high"
    source_count: 1

  rheumatoid_arthritis:
    pooled_hr: 1.68
    ci_95: [1.24, 2.28]
    outcome: "revision"
    evidence_strength: "moderate"
    source_count: 1

  chronic_kidney_disease:
    pooled_hr: 1.92
    ci_95: [1.45, 2.54]
    outcome: "revision"
    evidence_strength: "moderate"
    source_count: 1

  asa_class_4:
    pooled_hr: 2.84
    ci_95: [2.35, 3.43]
    outcome: "mortality"
    evidence_strength: "high"
    source_count: 1

  # Surgical factors
  smoking:
    pooled_hr: 1.52
    ci_95: [1.18, 1.96]
    outcome: "revision"
    evidence_strength: "moderate"
    source_count: 1

  prior_revision:
    pooled_hr: 1.78
    ci_95: [1.35, 2.35]
    outcome: "revision"
    evidence_strength: "high"
    source_count: 1

  # Bone defect classifications
  severe_bone_loss:
    pooled_hr: 2.15
    ci_95: [1.62, 2.85]
    outcome: "revision"
    evidence_strength: "high"
    source_count: 1

  paprosky_3b:
    pooled_hr: 2.85
    ci_95: [2.12, 3.84]
    outcome: "revision"
    evidence_strength: "high"
    source_count: 1

  pelvic_discontinuity:
    pooled_hr: 3.24
    ci_95: [2.28, 4.60]
    outcome: "revision"
    evidence_strength: "moderate"
    source_count: 1

  irradiated_pelvis:
    pooled_hr: 4.12
    ci_95: [2.85, 5.95]
    outcome: "revision"
    evidence_strength: "low"
    source_count: 1

# ============================================================================
# Benchmark Comparison Thresholds
# ============================================================================

comparison_thresholds:
  # For comparing study results to literature
  hhs_improvement:
    excellent: 40.0
    good: 35.0
    acceptable: 30.0
    concerning: 25.0

  mcid_rate:
    excellent: 0.75
    good: 0.65
    acceptable: 0.55
    concerning: 0.45

  revision_rate_2yr:
    excellent: 0.04
    good: 0.06
    acceptable: 0.08
    concerning: 0.10

  survival_2yr:
    excellent: 0.96
    good: 0.94
    acceptable: 0.92
    concerning: 0.90

  dislocation_rate:
    excellent: 0.03
    good: 0.05
    acceptable: 0.07
    concerning: 0.09
